Factor analysis of in vitro antitumor activities of platinum complexes

Factor analysis was applied to the data matrix of in vitro growth inhibitory activities of 52 platinum complexes against 9 tumor cell lines, L1210, P388, Lewis lung, AH66, AH66F, HeLa S3, KB, HT-1197 and HT-1376 cell lines. Three factors were obtained by the principal factor analysis method. After the varimax rotation of these three factors, tumor cell lines were classified into four groups according to their factor loadings. The platinum complexes were characterized by the factor scores. Cisplatin was situated in an extreme position as compared with the other platinum complexes. In vivo antitumor activities of the platinum complexes were tested against L1210 and LL murine tumor models. The in vivo activity against L1210 showed a negative correlation with that against LL. Factor 2 scores of the complexes obtained by factor analysis of in vitro antitumor activities showed a good correlation with these in vivo antitumor activities. Then, the structure-factor 2 score relationships among platinum complexes were analyzed by the Free-Wilson method. From this analysis, structure-activity relationships for carrier ligands and leaving groups are proposed. Factor analysis is suggested to be a useful method to establish an efficient screening system for platinum complexes.     

Combining aspects of the platinum anticancer drugs picoplatin and BBR3464 to synthesize a new family of sterically hindered dinuclear complexes; their synthesis, binding kinetics and cytotoxicity

Picoplatin is a sterically hindered mononuclear platinum drug undergoing clinical trials. The 2-methylpyridine ring provides steric hindrance to the drug, preventing attack from biological nucleophiles. BBR3464 is a trinuclear platinum drug which was recently in Phase II clinical trials, and is highly cytotoxic both in vitro and in vivo; it derives this activity through the flexible adducts it forms with DNA. In this work we sought to combine the properties of both drugs to synthesise a family of sterically hindered, dinuclear platinum complexes as potential anticancer agents. The bis-pyridyl-based ligands were synthesised through a peptide coupling reaction using diaminoalkanes of differing lengths (n = 2, 4 or 8) and 4-carboxypyridine or 2-methyl-4-carboxypyridine. The resultant dinuclear platinum complexes were synthesised by reacting two equivalents of transplatin or mono-aquated transplatin to each ligand, followed by purification by precipitation with acetone. The unprotected complexes react faster with 5'-guanosine monophosphate (drug to nucleotide ratio 1?:?2; t(1/2) = 2 h), glutathione (1?:?10, t(1/2) = 55 min) and human serum albumin (HSA) (1?:?1, t(1/2) = 24 h) compared to their hindered, protected equivalents (5'-guanosine monophosphate, t(1/2) = 3.5 h; glutathione = 1.7 h; HSA, t(1/2) = 110 h). The complexes were tested for in vitro cytotoxicity in the A2780 and A2780/cp70 ovarian cancer cell line. The unprotected platinum complexes were more cytotoxic than their protected derivatives, but none of the complexes were able to overcome resistance. The results provide important proof-of-concept for the development of a larger family of sterically hindered multinuclear-based platinum complexes.     

Platinum-catalyzed diastereoselective intramolecular coupling of allyl halides and hydrazones

Nucleophilic allyl platinum addition to hydrazones under platinum-catalyzed conditions was studied. To generate nucleophilic allyl platinum complexes, allyl halides were employed with platinum complexes, SnCl(2), and H(2). The allyl platinum(IV) intermediates reacted with the hydrazone to give the corresponding cyclic amine derivatives in good yield and with excellent diastereoselectivity. The cis selectivity of N-tethered substrates was attributed to a tight interaction of allyl platinum species with the hydrazone, on the basis of the results of solvent screening and acid/base addition experiments.     

Oxidation of Hydrogen by Metal Complexes of Platinum and Palladium Immobilized on Silica

The thermal stability of metal complexes immobilized on the surface of silica and its connection with the catalytic activity in the oxidation of hydrogen were investigated. High catalytic activity was exhibited by heterogenized platinum and palladium acetylacetonate near room temperatures in the initial state and by γ-aminopropylsilicas treated with platinum and palladium complexes. The catalytic activity of the metal complexes correlates with their thermal stability and with the ability to undergo oxidation to a metal state with high valence. This revised version was published online in August 2006 with corrections to the Cover Date.     

The unique chemistry of platina-beta-diketones

This review presents syntheses, structures and the reactivity of platina-beta-diketones [Pt2{(COR)2H}2(mu-Cl)2] (R = alkyl, omega-phenylalkyl), being the first electronically unsaturated (16 ve; ve-valence electrons) and kinetically labile metalla-beta-diketones. They were found to react with amines, yielding platina-beta-diketonates of platina-beta-diketones having Pt(4) zigzag chains analogous to platinum blue complexes. Reactions of platina-beta-diketones with monodentate and bidentate N-, P-, As-, O-, and S-donor ligands are described resulting in the formation of acyl(hydrido)platinum(IV) complexes, acyl(chloro)platinum(II) complexes, platinum complexes having enamine-amide type ligands, and of platinum(II) complexes with cyclic aminocarbene ligands, respectively. These reactions are discussed in terms of oxidative addition and reductive elimination reactions showing that platina-beta-diketones react as hydroxycarbene complexes whose OH groups are intramolecularly hydrogen-bridged to acyl ligands. Furthermore, the synthesis and structures of dinuclear platinum(II) complexes with bridging mu-acyl(hydroxycarbene) ligands are presented.     

Design and Preparation of Platinum–Acetylide Organogelators Containing Ethynyl–Pyrene Moieties as the Main Skeleton

A series of new platinum‐acetylide complexes containing ethynyl‐pyrene moieties as the main skeleton were synthesized and characterized. The investigation of the absorption and emission spectra of these complexes revealed that the extension of the molecular size with the introduction of different numbered platinum‐acetylide fragments can efficiently tune the absorption and emission bands from the UV to the longer wavelength region. Moreover, the gelation properties of these complexes were investigated by the “stable‐to‐inversion‐of‐a‐test‐tube” method. Most newly designed platinum‐acetylide compounds presented a stable gel‐formation property in some of the tested solvents. The morphology of the xerogels was investigated by scanning electron microscopy (SEM). Furthermore, the concentration‐ and temperature‐dependent absorption and emission properties of these complexes were investigated, which support the formation of J‐type assemblies during the aggregation process. More importantly, it was found that the complexes 4 a‐C6 , 4 a , and 4 a‐C18 with four platinum‐acetylide fragments presented potential applications as luminescent organometallic gels.     

Spectroscopic and biological properties of platinum complexes derived from 2-pyridyl Schiff bases

The reactions of a range of aromatic primary amines with pyridine-2-carboxaldehyde were reported, highlighting the effect of the substituents of the amine on the outcomes of the Schiff base reactions. The variant products of the Schiff base reactions were reacted with cis-[PtCl₂(DMSO)₂], generating platinum(II) complexes with PtCl₂(N^N) general formula. The ligands and platinum(II) complexes were identified and characterized by IR and NMR spectroscopic methods. Single crystal XRD offered structural confirmation for three of the organic compounds and two platinum complexes. The spectral, antimicrobial, DNA-binding and molecular docking of the platinum complexes were studied, highlighting the effect of the different functional group in the Schiff base ligands on their properties. In general, introducing the electron-withdrawing group nitro or acetyl in the 2-pyridyl Schiff base ligands, results in a red-shift in the absorption maxima of the platinum complex. In addition, the enhancement in the antimicrobial activities and the increase in the ct-DNA-binding affinity were also observed when the nitro or acetyl functional group is introduced to the Schiff base ligand in the platinum(II) complex.     

Synthesis and Photophysical Properties of Monometallic C^C* Platinum(II) Formamidinate Complexes using Sterically Demanding Ligands

A novel class of cyclometalated platinum(II) complexes—previously considered to be inaccessible—was synthesized by an improved synthetic route utilizing ligands predicted by density functional theory calculations. Based on a concise quantum chemical screening three model ligands with varying steric demand were chosen and a series of six photoluminescent C^C* cyclometalated platinum(II) formamidinate complexes was obtained. The least sterically demanding ligand led to a bimetallic complex in two isomeric forms, which could be separated and confirmed by the corresponding solid-state structures. Sterically more hindered amidinate ligands gave the monometallic complexes supporting the theoretical predictions. The monometallic complexes show a significant hypsochromic shift of the emission wavelength, explained by the loss of the metal-metal interactions. Depending on the cyclometalating ligand quantum yields up to 87 % with short decay times were found for this new class of phosphorescent green-blue to pure blue platinum(II) emitters.     

抗肿瘤铂配合物的研究进展

综述了30年来抗肿瘤铂配合物的研究进展,重点介绍了违背原有构效关系的铂的新型配合物的设计思想及研究情况,包括铂(Ⅳ)配合物、反式铂配合物、铂高分子配合物等。     

A comparison of the binding of metal complexes to duplex and quadruplex DNA

Electrospray ionisation mass spectrometry (ESI-MS) and circular dichroism (CD) spectroscopy were used to compare the binding of mononuclear nickel, ruthenium and platinum complexes to double stranded DNA (dsDNA) and quadruplex DNA (qDNA). CD studies provided evidence for the binding of intact complexes of all three metal ions to qDNA. ESI mass spectra of solutions containing platinum or ruthenium complexes and qDNA showed evidence for the formation of non-covalent complexes consisting of intact metal molecules bound to DNA. However, the corresponding spectra of solutions containing nickel complexes principally contained ions consisting of fragments of the initial nickel molecule bound to qDNA. In contrast ESI mass spectra of solutions containing nickel, ruthenium or platinum complexes and dsDNA only showed the presence of ions attributable to intact metal molecules bound to DNA. The fragmentation observed in mass spectral studies of solutions containing nickel complexes and qDNA is attributable to the lower thermodynamic stability of the former metal complexes relative to those containing platinum or ruthenium, as well as the slightly harsher instrumental conditions required to obtain spectra of qDNA. This conclusion is supported by the results of tandem mass spectral studies, which showed that ions consisting of intact nickel complexes bound to qDNA readily undergo fragmentation by loss of one of the ligands initially bound to the metal. The ESI-MS results also demonstrate that the binding affinity of each of the platinum and ruthenium complexes towards qDNA is significantly less than that towards dsDNA.     

N—取代亚胺二乙酸合铂配合物的合成,表征和反应

1969年,Rosenberg等报道顺式二氯二氨合铂(顺铂)具有抗癌作用,但它有很强的毒副作用和较差的水溶性.1986年,英国正式生产第二代铂抗癌药即碳铂.Khokhar等曾合成一系列N-烷基亚胺二乙酸环己二胺合铂配合物,体外和体内实验均表现出较高的活性和低毒性.其配体以二羧基与铂配位,为八元环结构.显然这不是热力学优势产物.本文合成了一系列二胺铂配合物,结果表明配体以N、O方式与铂配位,具有五元螯合环结构.顺铂与DNA发生交联(主要是与鸟嘌呤N7配位)而抑制癌细胞生长.不同类似物之间的活性差异较大,这可能与它们和DNA作用的动力学有关.我们以鸟苷作模型化合物,用HPLC方法研究了配合物与其作用的动力学,并与顺铂、碳铂进行比较.     

氨·二甲胺·羧酸根合铂(Ⅱ)类配合物的合成、抗肿瘤活性和与DNA的键合水平

本工作设计合成了6种新型混胺羧酸根合铂(Ⅱ)类配合物[Pt((?)NH)(NH₃)X₂](a～f){其中，X=CH₃COO^-(乙酸根)，CH₃Cl COO^-(氯乙酸根)，CHCl₂COO^-(二氯乙酸根)，C₆H₅-COO^-(苯甲酸根)，p-CH₃-C₆H₄-COO^-(对甲基苯甲酸根)，p-CH₃O-C₆H₄-COO^-(对甲氧基苯甲酸根)}。通过元素分析、摩尔电导、差热分析、红外光谱、紫外光谱和 ¹H核磁共振谱对配合物进行了表征。通过MTT法研究了配合物的体外抗肿瘤活性，通过等离子体质谱研究了配合物与细胞DNA的键合量；体外抗肿瘤活性测试表明，配合物(a～f)对所测试的肿瘤细胞MCF-7、HCT-8和BGC-823没有表现出活性，但对EJ和HL-60两种肿瘤细胞表现出好的活性，而且配合物(d～f)对HL-60细胞的活性与顺铂相当。配合物(a～f)与HL-60细胞的DNA键合量与其作用浓度表现出一定的依赖性，从小到大的顺序为：cisplatin < c < b < a < f < e < d。     

Insertion of (Bioactive) Equatorial Ligands into Platinum(IV) Complexes

Platinum(IV) prodrugs are highly interesting alternatives to platinum(II) anticancer therapeutics due to their increased tumor selectivity and reduced side effects. In contrast to the established theory, we recently observed that the equatorial ligand(s) of e.g. oxaliplatin(IV) complexes can be hydrolyzed with formation of [(DACH)Pt(OH_eq)₂(OAc_ax)₂]. In the work presented here, we investigated the reactivity and synthetic usability of this complex to be exploited as a precursor for the development of novel platinum(IV) complexes, not able to be synthesized by conventional protocols. Indeed, we could substitute the equatorial hydroxido ligand(s) e.g. by one or two monodentate biotin ligands (which would be oxidized under standard methods). The formed complexes turned out to be very stable with slow ligand release after reduction, ideal for long-circulating tumor-targeting strategies. Therefore, two platinum(IV) complexes with equatorial maleimides, capable of exploiting serum albumin as a natural nanocarrier, were synthesized as well. The complexes showed massively prolonged plasma half-life and distinctly improved anticancer activity in vivo compared to oxaliplatin. Taken together, the newly developed synthetic platform allows the simple and specific insertion of equatorial ligands into platinum(IV) complexes. This will enable the attachment of three different (bioactive) moieties generating targeted triple-action platinum(IV) prodrugs within one single platinum complex.     

Synthesis of platinum complexes of 2-aminomethylpyrrolidine derivatives for use as carrier ligands and their antitumor activities

In order to study a new antitumor platinum complex, various platinum complexes were prepared from 2-amino-methylpyrrolidine derivatives synthesized to serve as carrier ligands and tested for their antitumor activity against Colon 26 carcinoma (s.c.-i.p. system) and P388 leukemia (i.p.-i.p. system) in mice. 2-Aminomethylpyrrolidine proved to be the most effective carrier ligand in its amine derivatives. The structure-activity relationships of the carrier ligands in the platinum complexes with dichloro, oxalato, 1,1-cyclobutanedicarboxylato and dichlorodihydroxo as leaving group were clearly shown on the Colon 26 carcinoma screen and were as follows: the antitumor activity of the platinum complexes with any leaving groups was considerably decreased by the substitution of hydrogen by alkyl group (Me, Et) on nitrogen of aminomethyl and the effects of 1,1-cyclobutanedicarboxylato Pt(II) complexes completely disappeared with the same substitution on nitrogen of pyrrolidine. In all the tested platinum complexes 2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)platin um(II) (15) exhibited the most potent antitumor activity. 15 was superior to 1,1-cyclobutanedicarboxylatodiammineplatinum(II) (CBDCA) and similar to cis-diamminedichloroplatinum(II) (CDDP) on the Colon 26 carcinoma screen but it was inferior to CBDCA and CDDP on the P388 leukemia screen. Furthermore, 15 showed more potent antitumor activity than CBDCA against Colon 38 carcinoma (s.c.-i.p. system).     

Application of Silica Chemically Modified by Sulfur-Containing Groups to the Separation and Determination of Platinum and Rhenium in Catalysts Based on Aluminum Oxide

Adsorbents based on silica chemically modified by sulfur-containing groups (dithiocarbamate, thiodiazolethiol, mercaptophenyl, and aminobenzothiazole) quantitatively extract (recovery ≥99%) platinum( IV) from solutions ranging from 4 M HCl to pH 6. Under the conditions of the adsorption separation of platinum(IV), rhenium(VII) is not extracted and remains in the solution. The subsequent quantitative (98–99%) adsorption of rhenium(VII) is achieved in the presence of a 1000-fold excess of tin(II) chloride. Adsorption on the surface of adsorbents leads to the formation of platinum(II) complexes with sulfur-containing groups, luminescent at 77 K on irradiation with UV light. The luminescence spectra of surface platinum( II) complexes are located in the region of 550–700 nm. In the adsorption of rhenium(III) in the presence of tin(II) chloride, intensely colored brown complexes of rhenium formed on the surface of adsorbents. Electron paramagnetic resonance showed that, in the surface complexes, rhenium is in the oxidation state 2+. Silicas chemically modified by sulfur-containing groups were used in the development of procedures for the sequential isolation and determination of platinum and rhenium in solutions after the decomposition of aluminum–platinum–rhenium catalysts.     

XANES determination of the platinum oxidation state distribution in cancer cells treated with platinum(IV) anticancer agents

Here we describe the use of X-ray absorption near edge spectroscopy (XANES) to provide information about the relative proportions of platinum(II) and platinum(IV) complexes by analyzing the XANES edge height. The intracellular reduction of platinum(IV) complexes in cancer cells has been observed directly, and the proportion of reduction after 2 h was found to correlate with the reduction potentials of the complexes.     

Cytotoxicity of asymmetric platinum complexes against L-1210 cells. Effect of bulky substituents

The asymmetric platinum complexes cis-Pt(LL')Cl2 (L = NH3, L' = CH3NH2, (CH3)2NH, C2H5NH2 and (C2H5)2NH and LL' = N,N-dimethylethylenediamine),--one of the NH3 groups of cis-Pt(NH3)2Cl2 was substituted by alkylamine--, were synthesized and their cytotoxic effects have been measured using L-1210 cells. The IC50 values of the asymmetric platinum complexes,--being obtained after 24 h exposure of L-1210 cells to the platinum complexes--, are almost comparable to the corresponding value of cis-Pt(NH3)2Cl2. In 2 h exposure, however, the IC50 values of the platinum complexes were dramatically changed, i.e., a marked difference was observed between those of L' = RNH2 and L' = R2NH. On the other hand, the amounts of platinum taken into the L-1210 cells is little affected by the alkylamino substitution. The results suggest that the bifunctional platinum binding to the target molecule may be responsible for the cytotoxicity.     

Separation and identification of platinum adducts with DNA nucleotides by capillary zone electrophoresis and capillary zone electrophoresis coupled to mass spectrometry

Platinum adducts are supposed to be the cytotoxic lesions in DNA after platinum-containing anticancer therapy. Various adducts are formed upon interaction of platinum complexes with nucleotides, but contribution of individual adducts to antitumor activity and toxicity of platinum complexes still remains to be examined. A capillary zone electrophoresis (CZE) method is described that is suitable to separate individual platinum adducts. We investigated the formation of adducts following the reaction of cis-diamminedichloroplatinum (II) (cisplatin) with various DNA nucleotides. Baseline separation of unmodified and modified nucleotides (adducts) was achieved using uncoated fused-silica capillaries and basic separation buffers. In order to elucidate the observed peak pattern, a coupled CZE-electrospray ionization-mass spectrometry (ESI)-MS approach was applied. After incubation of mononucleotides with cisplatin, monochloro, monoaqua and bifunctional adduct species were detected. Consequently, the migration order of nucleotides and individual platinum adducts could be determined. Moreover, the time-dependent conversion from monochloro to monoaqua and subsequently to bifunctional adducts was monitored. In conclusion, individual platinum adducts were separated by CZE and identified by CZE-ESI-MS. Formation and conversion of distinct species were confirmed. Potential applications comprise studies of novel platinum complexes, investigations of platinum-adduct formation with DNA, and determination of platinum-DNA adducts in cells.     

The separation of platinum and palladium by selective extraction of H(2)Pt(SCN)(6) and H(2)Pd(SCN)(4) using a polyTHF-impregnated filter

Platinum and palladium are known to form complexes with the thiocyanate ion in solution. The isolation and separation of both platinum and palladium as thiocyanate complexes is demonstrated by passing them through an organic-impregnated filter (OIF) prepared with polyTHF. Simultaneous extraction is performed by converting both metals into the extractable form. Sequential extraction is achieved by exploiting the difference in the rates of formation for the extractable complexes of the two metals. The extraction of both metals is rapid with quantitative recoveries of platinum with flow rates as high as 600 ml min⁻¹ in small samples, while recoveries from larger volume samples were considerably lower. Once extracted, the metals can be removed from the OIF by conversion to a non-extractable form with a high pH eluting solution. The rapid separation, isolation and preconcentration of both platinum and palladium from aqueous samples is demonstrated.     

几种生物碱铂(Ⅱ)络合物的1H、13C-NMR研究

本文测定了具有抗癌活性的咖啡咽铂、茶碱铂、可可碱铂络合物的~1H和~(13)C-NMR谱,考察了络合前后生物碱配体~1H和~(13)C化学位移的变化,结合氢-铂、碳-铂偶合常数的测定,确定了各生物碱配位原子为咪唑环上双键氮,应用核磁共振技术搞清了与一般抗癌铂类络合物结构不同的咖啡咽铂等络合物的结构,并用异核选择去偶双共振技术对全部~(13)C和~1H谱线进行了归属。